Penn Ovarian Cancer Research Center
@Penn_OCRC
The OCRC serves as a catalyst to promote comprehensive and interdisciplinary research on ovarian cancer. The home of the Ovarian Cancer Research Syndicate!
ID:985610459205251074
15-04-2018 20:07:00
802 Tweets
747 Followers
795 Following
Thank you Maggie Mullen for an amazing Syndicate talk on the power of coupling RAD51 foci analysis with pRPA to define populations of patients that respond to platinum and PARPi therapy and do better! Tour de force! Washington University in St. Louis Penn Center for Genome Integrity BasserBRCA Ovarian Cancer Research Alliance Ovarcome
The call for proposals is just days away! Mucinous Ovarian Cancer Coalition/MOCC invites researchers to submit abstracts for requests of up to $50,000. Find the full guidelines here: hope4moc.org/researching/
Michael Frumovitz Katie Kurnit Jenny Mueller MD SGO
Good succinct summary of the microplastic mess. Recent evidence of presence in arteries, clots, and GI tract and correlation with adverse health outcomes
nature.com/articles/s4159… Nature Medicine
#Recurrence rates & #patterns of recurrence in stage IA #p53abn #endometrial cancer with & w/o myometrial invasion by Amy Jamieson
🔗 bit.ly/3W5xNLU
Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows
We’re proud of the Perelman School of Medicine trainees who are front and center at #AACR ! From medical students to postdoctoral fellows, these young scientists are sharing the latest research from Penn Medicine - Abramson Cancer Center Roger Greenberg Ronny Drapkin 🇮🇱 🇺🇸 Carmen Guerra Penn LDI
Thank you to Salvatore Condello from Indiana University for a wonderful Syndicate talk on ILK, FZD signaling in ovarian cancer and how disruption of tissue transglutaminase (TG2) interactions can drive response to therapy Ovarian Cancer Research Alliance Rivkin Center Daniela Matei Tina's Wish OCMF
Overall survival is improved in all comers in the RUBY study of #Immunotherapy + chemotherapy in advanced/recurrent #EndometrialCancer - 31% reduction in risk of death death c/w 16 month improvement!!! #gyncsm
Sachia S. Powell speaking at first ever #patient education session SGO! Sachia heard this morning that she felt heard and patients are important in #PowerofSharedPurpose #ovariancancer survivor on Parpi 2+ yrs- fatigue is real! Consider what drug is doing for pt!
Thrilled to introduce Dr. Marisa S. Bartolomei (Dr. Marisa Bartolomei ) as the new Director of the Center for Women's Health and Reproductive Medicine! Penn Medicine MD #WomensHealth #ResearchDirector
Thank you, Steven Skates Mass General Cancer Center, for a wonderful Syndicate talk on biomarker development, ROCA, and the 'glass half full' for early detection of ovarian cancer!
Drs. Sara Buhrlage, Ronny Drapkin 🇮🇱 🇺🇸 and Marto at Dana-Farber and Penn Medicine are examining specific epigenetic changes that lead to the malignant transformation of epithelial cells in the fallopian tubes.
To learn more, visit tinaswish.org/portfolio/buhr…
Interesting paper. TEs never cease to amaze me. Now I’m wondering if dog breeds with no tail (Corgis, bulldog, etc) have some SINE or other TE insertion at TBXT gene compared to other breeds! Congratulations Itai Yanai 💔 and team.
Such an exciting moment for OBGYN Penn Medicine as Dr. Clarisa Gracia and Madeleine Duey Low took the spotlight at the Sixers game last night! Dr. Gracia’s commitment to women’s health shines brightly on and off the court. #OBGYN #Oncofertility Clarisa Gracia Penn Medicine MD
The latest Syndicate talk featured an exciting new myc-driven mouse model of ovarian cancer from Joe R Delaney at MUSC Health. Tremendous opportunity for collaboration. Thank you Joe!